From Medscape Gastroenterology

Medscape Medical News from:

The Liver Meeting 2012: American Association for the Study of Liver Diseases (AASLD) 63rd Annual Meeting

November 09 - 13, 2012; Boston, Massachusetts

This coverage is not sanctioned by, nor a part of, the American Association for the Study of Liver Diseases.

Conference News

AASLD Direct Anti-HCV Drugs Show Good Response in Routine Practice
Medscape Medical News, November 30, 2012
AASLD NAFLD Without Cirrhosis Linked to Liver Cancer Risk
Medscape Medical News, November 29, 2012
AASLD Early Cirrhosis Common in Children With Cystic Fibrosis
Medscape Medical News, November 28, 2012
AASLD Liver Cancer Risk Remains After HBV Treatment
Medscape Medical News, November 28, 2012
AASLD Coffee May Lower Risk for Severe Liver Fibrosis in NAFLD
Medscape Medical News, November 22, 2012
AASLD Bariatric Surgery Linked to Acetaminophen Liver Failure Risk
Medscape Medical News, November 21, 2012
AASLD Treated HBV Linked to Lower Risk for Liver Cancer Recurrence
Medscape Medical News, November 16, 2012
AASLD Interferon-Free Regimens Produce High HCV Sustained Response
Medscape Medical News, November 13, 2012
AASLD Healthcare Workers May Need HBV Boosters as Titers Drop
Medscape Medical News, November 12, 2012
AASLD Sarcopenia Does Not Raise Liver Transplant Mortality Risk
Medscape Medical News, November 11, 2012

Medscape Gastroenterology© WebMD, LLC

Previous AASLD Coverage

The Liver Meeting 2011

The Liver Meeting 2010

The Liver Meeting 2009